These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15991121)

  • 1. Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative.
    Kwong LM
    J Arthroplasty; 2005 Jun; 20(4 Suppl 2):12-4. PubMed ID: 15991121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of venous thromboembolism prophylaxis after surgery.
    Kearon C
    Chest; 2003 Dec; 124(6 Suppl):386S-392S. PubMed ID: 14668422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
    Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
    N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with ximelagatran in orthopaedic surgery.
    Eriksson B
    Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current recommendations for extended out-of-hospital thromboprophylaxis following total hip arthroplasty.
    Krotenberg R
    Am J Orthop (Belle Mead NJ); 2004 Apr; 33(4):180-4. PubMed ID: 15132325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthopaedic surgery as a model for drug development in thrombosis.
    Dahl OE
    Drugs; 2004; 64 Suppl 1():17-25. PubMed ID: 15586624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.
    Donohoe CL; Sayana MK; Thakral R; Niall DM
    Ir J Med Sci; 2011 Sep; 180(3):627-32. PubMed ID: 21286842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism debate in joint arthroplasty.
    Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
    J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for thromboprophylaxis in lower joint arthroplasty.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    An VV; Phan K; Levy YD; Bruce WJ
    J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty.
    Friedman RJ
    J Am Acad Orthop Surg; 2007 Mar; 15(3):148-55. PubMed ID: 17341671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's New in Venous Thromboembolic Prophylaxis Following Total Knee and Total Hip Arthroplasty? An Update.
    Pierce TP; Elmallah RK; Jauregui JJ; Cherian JJ; Mont MA
    Surg Technol Int; 2015 May; 26():234-7. PubMed ID: 26055015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
    Anderson FA; Hirsh J; White K; Fitzgerald RH;
    Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.